Funding Scientists at the Peak Age of Discovery Act of 2014

Bill: 113-hr-5819
Sponsor: full_name: Rep. Harris, Andy [R-MD-1]
Introduced: 2014-12-09
Policy area: Science, Technology, Communications
Subjects: Aging

Health programs administration and funding

Medical research

Research administration and funding
Latest action: action_date: 2014-12-12
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2014-12-09
action_desc: Introduced in House
text: <p>Funding Scientists at the Peak Age of Discovery Act of 2014 - Amends the Public Health Service Act to require the Director of the National Institutes of Health (NIH) to ensure that the median age of first-time researchers receiving R series (research) grants is under 40 years of age by January 1, 2019, under 39 years of age by January 1, 2022, and under 38 years of age by January 1, 2025. Excludes grants for small business innovation research, small business technology transfer, or clinical trial planning.</p>

tv_txt: I 113th CONGRESS 2d Session H. R. 5819 IN THE HOUSE OF REPRESENTATIVES December 9, 2014 Mr. Harris introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend title IV of the Public Health Service Act to ensure that scientists are being funded at the age when they are most likely to make breakthroughs.

1. Short title This Act may be cited as the Funding Scientists at the Peak Age of Discovery Act of 2014 . 2. Funding scientists at peak age of discovery Part A of title IV of the Public Health Service Act ( 42 U.S.C. 283 et seq. ) is amended by adding at the end the following: 404M. Funding scientists at peak age of discovery (a) In general The Director of NIH shall ensure that the median age of first-time researchers receiving grants in the R series from the institutes, centers, and offices of the National Institutes of Health— (1) by January 1, 2019, is under 40 years of age; (2) by January 1, 2022, is under 39 years of age; and (3) by January 1, 2025, is under 38 years of age. (b) Exceptions Subsection (a) does not apply with respect to grants in the R series which are determined by the head of the respective institute, center, or office to be within any of the following categories: (1) Small business innovation research. (2) Small business technology transfer. (3) Clinical trial planning. (c) Definition In this section: (1) The term first-time researcher means a researcher who has not previously served as the principal investigator for a research project supported by the National Institutes of Health through a grant in the R series. (2) The term R series refers the category of grants that are designated by the National Institutes of Health to be covered by— (A) the activity code relating to research projects (as such activity code is in effect on the date of enactment of this section); or (B) any successor activity code. .